
    
      An Open Label, Randomized, 2-period, 2- Treatment, 2-Sequence, Crossover, Single-dose
      Bioequivalence Study of Olmesartan Medoxomil Tablets containing Olmesartan Medoxomil 40 mg
      (Test Formulation, Torrent Pharmaceutical Ltd., India) Versus BenicarÂ® 40 mg Tablets
      containing Olmesartan Medoxomil 40 mg (Reference, Daiichi Sankyo Inc.,USA) in Healthy Human
      Volunteers Under Fasting Condition.
    
  